Adage Capital Partners Gp, L.L.C. Pep Gen Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $52.3 Billion
- Q2 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Pep Gen Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,327,536 shares of PEPG stock, worth $11.7 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,327,536
Previous 1,333,611
0.46%
Holding current value
$11.7 Million
Previous $19.6 Million
8.07%
% of portfolio
0.04%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding PEPG
# of Institutions
59Shares Held
24.7MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.7MShares$94.1 Million2.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY1.52MShares$13.4 Million1.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.5MShares$13.2 Million1.41% of portfolio
-
Viking Global Investors LP1.48MShares$13 Million0.09% of portfolio
-
Perceptive Advisors LLC New York, NY1.41MShares$12.4 Million0.65% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $208M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...